Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Maitre

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Infectious Diseases Now|October 15, 2023
Optimizing the use of current antituberculosis drugs to overcome drug resistance in Mycobacterium tuberculosisThomas Maitre, Alain Baulard, Alexandra Aubry, et al.
La Revue Du Praticien|March 29, 2024
[Advances in antibiotic therapy for tuberculosis]Thomas Maitre, Lorenzo Guglielmetti, Jérôme Robert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Poor Performance of Rapid Molecular Tests to Define Eligibility for the Shortcourse Multidrug-resistant Tuberculosis RegimenLorenzo Guglielmetti, Wladimir Sougakoff, Thomas Maitre, et al.
ERJ Open Research|September 10, 2025
Exploring lung cavity access to endobronchial valve in chronic pulmonary aspergillosis and nontuberculosis mycobacterial diseases, a radiological feasibility studyThomas Maitre, Matthias Barral, Juliette Camuset, et al.
The European Respiratory Journal|August 25, 2018
Increasing burden of noninfectious lung disease in persons living with HIV: a 7-year study using the French nationwide hospital administrative databaseThomas Maitre, Jonathan Cottenet, Guillaume Beltramo, et al.
Frontiers in Microbiology|March 7, 2020
Rational Choice of Antibiotics and Media for <i>Mycobacterium avium</i> Complex Drug Susceptibility TestingJérémy Jaffré, Alexandra Aubry, Thomas Maitre, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2024
Levofloxacin activity at increasing doses in a murine model of fluoroquinolone-susceptible and -resistant tuberculosisThomas Maitre, Alexandre Godmer, Céline Mory, et al.
Current HIV Research|September 7, 2019
Benefits and Limits of Antiretroviral Drug Monitoring in Routine PracticeThomas Maitre, Patrice Muret, Mathieu Blot, et al.
The European Respiratory Journal|January 22, 2021
Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosisThomas Maitre, Jonathan Cottenet, Cendrine Godet, et al.
The Journal of Antimicrobial Chemotherapy|May 24, 2017
Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis?Thomas Maitre, Grégoire Petitjean, Aurélie Chauffour, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Infectious Diseases Now|October 15, 2023
Optimizing the use of current antituberculosis drugs to overcome drug resistance in Mycobacterium tuberculosisThomas Maitre, Alain Baulard, Alexandra Aubry, et al.
La Revue Du Praticien|March 29, 2024
[Advances in antibiotic therapy for tuberculosis]Thomas Maitre, Lorenzo Guglielmetti, Jérôme Robert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Poor Performance of Rapid Molecular Tests to Define Eligibility for the Shortcourse Multidrug-resistant Tuberculosis RegimenLorenzo Guglielmetti, Wladimir Sougakoff, Thomas Maitre, et al.
ERJ Open Research|September 10, 2025
Exploring lung cavity access to endobronchial valve in chronic pulmonary aspergillosis and nontuberculosis mycobacterial diseases, a radiological feasibility studyThomas Maitre, Matthias Barral, Juliette Camuset, et al.
The European Respiratory Journal|August 25, 2018
Increasing burden of noninfectious lung disease in persons living with HIV: a 7-year study using the French nationwide hospital administrative databaseThomas Maitre, Jonathan Cottenet, Guillaume Beltramo, et al.
Frontiers in Microbiology|March 7, 2020
Rational Choice of Antibiotics and Media for <i>Mycobacterium avium</i> Complex Drug Susceptibility TestingJérémy Jaffré, Alexandra Aubry, Thomas Maitre, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2024
Levofloxacin activity at increasing doses in a murine model of fluoroquinolone-susceptible and -resistant tuberculosisThomas Maitre, Alexandre Godmer, Céline Mory, et al.
Current HIV Research|September 7, 2019
Benefits and Limits of Antiretroviral Drug Monitoring in Routine PracticeThomas Maitre, Patrice Muret, Mathieu Blot, et al.
The European Respiratory Journal|January 22, 2021
Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosisThomas Maitre, Jonathan Cottenet, Cendrine Godet, et al.
The Journal of Antimicrobial Chemotherapy|May 24, 2017
Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis?Thomas Maitre, Grégoire Petitjean, Aurélie Chauffour, et al.
Pageof 3